Michael Wong, MD, PhD

Allen P. and Josephine B. Green Professor of Pediatric Neurology

Phone314-454-6120

Fax314-454-4225

Emailwong_m@wustl.edu

Additional Titles

  • Associate Professor, Pediatrics
  • Associate Professor, Neurobiology
  • Director, Tuberous Sclerosis Clinic

Board Certifications

  • Pediatric Neurology - Certified
  • Neurology - Certified
  • Clinical Neurophysiology - Certified

Related Links

Recognition

  • Listed in Best Doctors in America, 2006-2013 (Best Doctors, Inc.)
  • American Epilepsy Society, 2001-present
  • American Academy of Neurology, 1998-present
  • Society for Neuroscience, 1989-present

Publications

  • Zhang B, McDaniel SS, Rensing NR, Wong M. Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex. PLoS One. 2013;8(2):e57445.
  • Coorg R, Weisenberg JL, Wong M. Clinical neurogenetics: recent advances in the genetics of epilepsy. Neurol Clin. 2013 Nov;31(4):891-913.
  • Wong M, Guo D. Dendritic spine pathology in epilepsy: cause or consequence? Neuroscience. 2013 Oct 22;251:141-50.
  • Wong M. A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials. Expert Rev Neurother. 2013 Jun;13(6):657-69.
  • Guo D, Zeng L, Brody DL, Wong M. Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury. PLoS One. 2013 May 14;8(5):e64078.
  • Wong M. Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed J. 2013 Mar-Apr;36(2):40-50.
  • Guo D, Zeng L, Brody DL, Wong M. Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury. PLoS One. 2013 May 14;8(5):e64078.
  • Wong M. Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed J. 2013 Mar-Apr;36(2):40-50.
  • Ciliberto MA, Weisenberg JL, Wong M. Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy. Drug Healthc Patient Saf. 2012;4:81-6.
  • Rensing NR, Guo D, Wong M. Video-EEG monitoring methods for characterizing rodent models of tuberous sclerosis and epilepsy. Methods Mol Biol. 2012;821:373-91.
  • Wong M. mTOR as a potential treatment target for epilepsy. Future Neurol. 2012 Sep 1;7(5):537-545.
  • Ryther RC, Wong M. Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy. Curr Neurol Neurosci Rep. 2012 Aug;12(4):410-8.
  • Wong M, Crino PB. Tuberous sclerosis and epilepsy: role of astrocytes. Glia. 2012 Aug;60(8):1244-50.
  • Anyaegbu E, Goodman M, Ahn SY, Thangarajh M, Wong M, Shinawi M. Acute intermittent porphyria: a diagnostic challenge. J Child Neurol. 2012 Jul;27(7):917-21.
  • Park JM, Tuuli MG, Wong M, Carbone JF, Ismail M, Macones GA, Odibo AO. Cervical cerclage: one stitch or two? Am J Perinatol. 2012 Jun;29(6):477-81.
  • Zhang B, Wong M. Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in rat. Epilepsia. 2012 Mar;53(3):506-11.

Dr. Wong is a board-certified pediatric neurologist, specializing in clinical pediatric epilepsy and basic epilepsy research. As part of the Pediatric Epilepsy Center, Dr. Wong’s clinical responsibilities include outpatient epilepsy clinic and inpatient neurology attending, as well as interpretation of EEG and long-term video-EEG monitoring studies at St. Louis Children’s Hospital. He also serves as Director of the Washington University Tuberous Sclerosis Clinic, one of several recognized specialty clinics devoted to patients with Tuberous Sclerosis in the United States. Dr. Wong is board certified by the American Board of Psychiatry and Neurology with Special Qualification in Child Neurology, the American Board of Psychiatry and Neurology with Special Qualification in Clinical Neurophysiology, and the American Board of Clinical Neurophysiology (Epilepsy Monitoring Track). He is named in the Best Doctors in America for Child Neurology and has been awarded a number of federal and private research grants to study epilepsy. He received the Dreifuss-Penry Epilepsy Award from the American Academy of Neurology in 2009